A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response

Kidney Int. 2021 Nov;100(5):1132-1135. doi: 10.1016/j.kint.2021.08.017. Epub 2021 Aug 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19* / immunology
  • Humans
  • Immunity, Humoral
  • Kidney Transplantation*
  • Transplant Recipients

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine